Molecular Characterization of Helodermin-Preferring VIP Receptors in SUP T₁Lymphoma Cells: Evidence for Receptor Glycosylation

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1970 • 253,849 citations

A highly sensitive adenylate cyclase assay

1974 • 4,213 citations

Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines.

1984 • 244 citations

Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Binding of radioiodinated peptide.

1976 • 214 citations

Common Region on Chromosome 14 in T-Cell Leukemia and Lymphoma

1984 • 174 citations

Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts.

1985 • 125 citations

N-glycosylation in expression and function of beta-adrenergic receptors.

1986 • 92 citations

Role of glycosylation and protein synthesis in insulin receptor metabolism by 3T3-L1 mouse adipocytes.

1981 • 89 citations

The Human Vasoactive Intestinal Peptide Receptor: Molecular Identification by Covalent Cross-Linking in Colonic Epithelium*

1985 • 74 citations

The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor

1985 • 69 citations

Vasoactive intestinal peptide (VIP) receptor on liver plasma membranes: characterization as a glycoprotein

1986 • 63 citations

A new type of functional VIP receptor has an affinity for helodermin in human SUP‐T1 lymphoblasts

1988 • 62 citations

Covalent cross‐linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29)

1985 • 58 citations

Chemical, immunological and biological properties of peptides like vasoactive‐intestinal‐peptide and peptide‐histidine‐isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum)

1987 • 58 citations

Molecular Analysis of Vasoactive Intestinal Peptide Receptors: A Comparison with Receptors for VIP‐Related Peptides

1988 • 57 citations

Characterization of Vasoactive Intestinal Peptide (VIP) receptors in mammalian lung

1986 • 54 citations

Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.

1988 • 52 citations

Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29

1985 • 47 citations

Specific labelling by [¹²⁵I]helodermin of high‐affinity VIP receptors in rat liver membranes

1984 • 45 citations

Glycosylation of CD4. Tunicamycin inhibits surface expression.

1988 • 45 citations

Effects of HIS1 modifications on the ability of vasoactive intestinal peptide to stimulate adenylate cyclase from rat and human tissues

1984 • 42 citations

Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes

1989 • 38 citations

Deglycosylated mammalian β2-adrenergic receptors: Effect on radioligand binding and peptide mapping

1985 • 28 citations

Species differences in the molecular characteristics of vasoactive‐intestinal‐peptide receptors in the pancreas from rat and guinea‐pig

1988 • 17 citations

Adenylate cyclase activation by VIP-helodermin and histamine H2 receptors in human THP-1 monocytes/macrophages: A possible role in the regulation of superoxide anions production

1989 • 10 citations

Vasoactive intestinal peptide and its receptors in fetuses with cystic fibrosis

1989 • 9 citations

The Glycoprotein Nature of the Vasoactive Intestinal Peptide Binding Site. Role of Carbohydrates in VIP Binding on HT 29‐D4 Cells^a

1988 • 8 citations

Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma (SCLC) cell lines

1989 • 3 citations

Helodermin-preferring 125I-VIP binding sites during the postnatal development of the pancreas

1989 • 1 citations